A photo of Theodosia A. Kalfa.

Theodosia A. Kalfa, MD, PhD


  • Co-Director, Erythrocyte Diagnostic Laboratory
  • Professor, UC Department of Pediatrics

About

Additional Languages

Greek

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Selected

VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects. Seu, KG; Trump, LR; Emberesh, S; Lorsbach, RB; Johnson, C; Meznarich, J; Underhill, HR; Chou, ST; Sakthivel, H; Nassar, NN; et al. American Journal of Human Genetics. 2020; 107:1149-1156.

Selected

Red cell membrane disorders: structure meets function. Risinger, M; Kalfa, TA. Blood. 2020; 136:1250-1261.

Selected

Signaling and cytoskeletal requirements in erythroblast enucleation. Konstantinidis, DG; Pushkaran, S; Johnson, JF; Cancelas, JA; Manganaris, S; Harris, CE; Williams, DA; Zheng, Y; Kalfa, TA. Blood. 2012; 119:6118-6127.

M-CSF supports medullary erythropoiesis and erythroid iron demand following burn injury through its activity on homeostatic iron recycling. Noel, JG; Ramser, SW; Pitstick, L; Bonamer, JP; Mackenzie, B; Seu, KG; Kalfa, TA; Cancelas, JA; Gardner, JC. Scientific Reports. 2022; 12.

De Novo Germline DHX38 Variant Associated with Alternative Splicing of Multiple Transcripts in Iron-Related Pathways in a Patient with Atypical Congenital Dyserythropoietic Anemia with Ring Sideroblasts. Voulgaridou, A; Elgammal, Y; Husami, A; Emberesh, S; Seu, K; Ramamoorthy, M; Trump, L; Barasa, N; Nelson, AS; Lorsbach, RB; et al. Blood. 2022; 140:1234-1235.

Dominant-Negative VPS4A Mutations Causing Congenital Dyserythropoietic Anemia Disrupt Iron Trafficking of Terminal Erythropoiesis. Seu, K; Voulgaridou, A; Stewart, M; Meznarich, J; Johnson, C; Junge, H; Mackenzie, B; Blanc, L; Cancelas, JA; Kalfa, TA. Blood. 2022; 140:8190-8191.

Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis. Romano, L; Seu, KG; Papoin, J; Muench, DE; Konstantinidis, D; Olsson, A; Schlum, K; Chetal, K; Chasis, JA; Mohandas, N; et al. Blood. 2022; 140:1621-1634.

Insane in the membrane: A case of hereditary spherocytic pyropoikilocytosis. Gibson, SJ; Kalfa, TA; DeStefano, CB. American Journal of Hematology. 2022; 97:1384-1385.

MPN-024 Hypereosinophilic Syndrome: A Catastrophic Pediatric Case. Bello, A; Casanova, A; Arias, A; Kalfa, T; Kussick, S. Clinical Lymphoma, Myeloma and Leukemia. 2022; 22 Suppl 2.

Poster: MPN-024 Hypereosinophilic Syndrome: A Catastrophic Pediatric Case. Bello, A; Casanova, A; Arias, A; Kalfa, T; Kussick, S. Clinical Lymphoma, Myeloma and Leukemia. 2022; 22.

From the Blog


Blood Cell Production Discovery Opens Path to Improve Anemia of Inflammation
Tools for Science

Blood Cell Production Discovery Opens Path to Improve Anemia of Inflammation

Theodosia A. Kalfa, MD, PhD10/31/2022

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey